Atlas Venture Fund X, L.P.
Related Filers (22)
- Atlas Venture Associates X, LLC (26)
- ATLAS VENTURE ASSOCIATES X, L.P. (26)
- Atlas Venture Opportunity Fund I, L.P. (19)
- Disc Medicine, Inc. (18)
- Atlas Venture Associates Opportunity I, LLC (16)
- Atlas Venture Associates Opportunity I, L.P. (16)
- Replimune Group, Inc. (13)
- Kymera Therapeutics, Inc. (12)
- Dianthus Therapeutics, Inc. /DE/ (11)
- Generation Bio Co. (9)
- AVROBIO, Inc. (6)
- Ikena Oncology, Inc. (3)
- Spero Therapeutics, Inc. (2)
- Atlas Venture Fund XI, L.P. (2)
- Atlas Venture Associates XI, LLC (2)
- Atlas Venture Associates XI, L.P. (2)
- Atlas Venture Associates XII, LLC (1)
- Atlas Venture Fund XII, L.P. (1)
- Atlas Venture Associates XII, L.P. (1)
- Atlas Venture Associates Opportunity II, LP (1)
- Atlas Venture Associates Opportunity II, LLC (1)
- Atlas Venture Opportunity Fund II, L.P. (1)
- Show More ...
Other (8)
144
Tuesday, 1/23/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 1/10/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 9/15/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 9/14/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/15/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/14/2023
Filing for proposed sale of securities under Rule 144
D
Thursday, 12/18/2014
Exempt (Private) Offering
Ownership (66)
SC 13G/A
Friday, 2/9/2024
Kymera Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/9/2024
Generation Bio Co.: Major Shareholders
4
Thursday, 1/25/2024
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 1/25/2024
Disc Medicine, Inc.: Major Shareholders
4
Friday, 1/12/2024
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/14/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 9/21/2023
Disc Medicine, Inc.: Major Shareholders
4
Monday, 9/18/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 9/15/2023
Dianthus Therapeutics, Inc. /DE/: Major Shareholders
4
Wednesday, 8/16/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 2/14/2023
Disc Medicine, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Kymera Therapeutics, Inc.: Major Shareholders
4
Friday, 1/13/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 12/6/2022
Replimune Group, Inc.: Major Shareholders
4
Friday, 11/4/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 9/14/2022
Replimune Group, Inc.: Major Shareholders
SC 13D/A
Thursday, 5/5/2022
Magenta Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Generation Bio Co.: Major Shareholders
SC 13D
Friday, 2/11/2022
Ikena Oncology, Inc.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Kymera Therapeutics, Inc.: Major Shareholders
4
Tuesday, 9/21/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/1/2021
Ikena Oncology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/25/2021
Ikena Oncology, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 3/18/2021
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Monday, 2/22/2021
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 2/17/2021
Magenta Therapeutics, Inc.: Major Shareholders
SC 13D
Tuesday, 2/16/2021
Gemini Therapeutics, Inc. /DE: Major Shareholders
4
Tuesday, 2/16/2021
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
Kymera Therapeutics, Inc.: Major Shareholders
SC 13D/A
Tuesday, 2/16/2021
Spero Therapeutics, Inc.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Generation Bio Co.: Major Shareholders
3
Thursday, 2/11/2021
Gemini Therapeutics, Inc. /DE: Initial statement of beneficial ownership of securities
4
Thursday, 12/17/2020
Generation Bio Co.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/17/2020
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 9/17/2020
Replimune Group, Inc.: Major Shareholders
4
Tuesday, 8/25/2020
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/20/2020
Kymera Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 7/14/2020
Magenta Therapeutics, Inc.: Major Shareholders
SC 13D/A
Tuesday, 7/7/2020
Replimune Group, Inc.: Major Shareholders
4
Tuesday, 7/7/2020
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 6/19/2020
Replimune Group, Inc.: Major Shareholders
4
Thursday, 6/18/2020
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/18/2020
Generation Bio Co.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/11/2020
Generation Bio Co.: Initial statement of beneficial ownership of securities
SC 13G/A
Thursday, 2/13/2020
Magenta Therapeutics, Inc.: Major Shareholders
SC 13D
Monday, 11/25/2019
Replimune Group, Inc.: Major Shareholders
SC 13D
Tuesday, 7/30/2019
AVROBIO, Inc.: Major Shareholders
4/A
Monday, 7/29/2019
AVROBIO, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/23/2019
AVROBIO, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/22/2019
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/14/2019
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Wednesday, 2/13/2019
Replimune Group, Inc.: Major Shareholders
SC 13G
Wednesday, 2/13/2019
AVROBIO, Inc.: Major Shareholders
SC 13G
Wednesday, 2/13/2019
Magenta Therapeutics, Inc.: Major Shareholders
4
Thursday, 7/26/2018
Replimune Group, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/19/2018
Replimune Group, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/27/2018
Magenta Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/25/2018
AVROBIO, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/20/2018
Magenta Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/20/2018
AVROBIO, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Wednesday, 3/14/2018
Spero Therapeutics, Inc.: Major Shareholders